Effect of Prunella vulgaris L extract on hyperplasia of mammary gland in rats
Purpose: To explore the effects of Prunella vulgaris L extract (PVE) on hyperplasia of mammary gland (HMG) in rats.
Methods: Forty virgin female Wistar rats were randomly divided into normal group, control group (HMG model), positive control group (Rupixiao Capsule, RPXC), and low-, medium- and high-dose (150, 300 and 600 mg/kg) of PVE groups. Injections of estrogen and progestogen were given at the same time to prepare rat. Changes in nipple height were measured, while serum estradiol (E2), progesterone (P), prolactin (PRL), follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were evaluated by ELISA; Uterus and ovary indices were determined.
Results: Compared with control group, PVE reduced elevated nipple height to 2.25 ± 0.09 mm (p < 0.01) and uterus index to 2.29 ± 0.41 mg/g (p < 0.01), as well as reduced the number of mammary gland lobules and secretion in HMG rats. Compared with control group, serum E2 (2.81 ± 0.17 pmol/L), PRL (269.38 ± 8.28 pg/mL) and FSH (0.13 ± 0.03 IU/L) levels (p < 0.01) were lowered, but serum P (1.31 ± 0.13 ng/mL) and LH (1.73 ± 0.08 mIU/mL) levels were higher (p < 0.01) in rats treated with highdose PVE.
Conclusion: These results suggest that PVE exerts anti-HMG effect in rats induced by estrogen and progestogen.
Keywords: Prunella vulgaris L; Anti-inflammatory; Anti-hyperplasia of mammary gland
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.